Cargando…

Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus

The ichroma Chikungunya virus (CHIKV) IgG/IgM (Boditech Med Inc., Chuncheon, Korea) is a newly developed rapid lateral flow immunoassay for detection of anti- CHIKV-IgG/IgM. This study conducted with thirty-six anti-CHIKV IgG positive sera, 57 anti-CHIKV IgM positive sera and 163 anti-CHIKV IgG/IgM...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyeyoung, Ryu, Ji Hyeong, Yun, Sojeong, Jang, Joo Hee, Choi, Ae-Ran, Cho, Sung-Yeon, Park, Chulmin, Lee, Dong-Gun, Oh, Eun-Jee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779981/
https://www.ncbi.nlm.nih.gov/pubmed/32757502
http://dx.doi.org/10.3947/ic.2020.52.4.611
_version_ 1783631425341227008
author Lee, Hyeyoung
Ryu, Ji Hyeong
Yun, Sojeong
Jang, Joo Hee
Choi, Ae-Ran
Cho, Sung-Yeon
Park, Chulmin
Lee, Dong-Gun
Oh, Eun-Jee
author_facet Lee, Hyeyoung
Ryu, Ji Hyeong
Yun, Sojeong
Jang, Joo Hee
Choi, Ae-Ran
Cho, Sung-Yeon
Park, Chulmin
Lee, Dong-Gun
Oh, Eun-Jee
author_sort Lee, Hyeyoung
collection PubMed
description The ichroma Chikungunya virus (CHIKV) IgG/IgM (Boditech Med Inc., Chuncheon, Korea) is a newly developed rapid lateral flow immunoassay for detection of anti- CHIKV-IgG/IgM. This study conducted with thirty-six anti-CHIKV IgG positive sera, 57 anti-CHIKV IgM positive sera and 163 anti-CHIKV IgG/IgM negative sera which were confirmed by commercial enzyme-linked immunosorbent assays (ELISAs) (Inbios CHIKjj Detect™ IgM Capture ELISA, Inbios CHIKjj Detect™ IgG ELISA (InBios International Inc., Seattle, WA, USA), Anti-CHIKV ELISA (IgM), Anti- CHIKV ELISA (IgG) (Euroimmun, Lübeck, Germany)). The ichroma detected all 36 anti-CHIKV IgG and 57 anti-CHIKV IgM positivity (100% sensitivity). For 163 anti-CHIKV IgG/IgM negative sera, the ichroma showed one false positive for IgM (99.4% specificity). The ichroma showed no cross-reactivity and no interference. The ichroma demonstrated good diagnostic performance compared to the current ELISAs.
format Online
Article
Text
id pubmed-7779981
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS
record_format MEDLINE/PubMed
spelling pubmed-77799812021-01-05 Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus Lee, Hyeyoung Ryu, Ji Hyeong Yun, Sojeong Jang, Joo Hee Choi, Ae-Ran Cho, Sung-Yeon Park, Chulmin Lee, Dong-Gun Oh, Eun-Jee Infect Chemother Brief Communication The ichroma Chikungunya virus (CHIKV) IgG/IgM (Boditech Med Inc., Chuncheon, Korea) is a newly developed rapid lateral flow immunoassay for detection of anti- CHIKV-IgG/IgM. This study conducted with thirty-six anti-CHIKV IgG positive sera, 57 anti-CHIKV IgM positive sera and 163 anti-CHIKV IgG/IgM negative sera which were confirmed by commercial enzyme-linked immunosorbent assays (ELISAs) (Inbios CHIKjj Detect™ IgM Capture ELISA, Inbios CHIKjj Detect™ IgG ELISA (InBios International Inc., Seattle, WA, USA), Anti-CHIKV ELISA (IgM), Anti- CHIKV ELISA (IgG) (Euroimmun, Lübeck, Germany)). The ichroma detected all 36 anti-CHIKV IgG and 57 anti-CHIKV IgM positivity (100% sensitivity). For 163 anti-CHIKV IgG/IgM negative sera, the ichroma showed one false positive for IgM (99.4% specificity). The ichroma showed no cross-reactivity and no interference. The ichroma demonstrated good diagnostic performance compared to the current ELISAs. The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2020-12 2020-07-24 /pmc/articles/PMC7779981/ /pubmed/32757502 http://dx.doi.org/10.3947/ic.2020.52.4.611 Text en Copyright © 2020 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communication
Lee, Hyeyoung
Ryu, Ji Hyeong
Yun, Sojeong
Jang, Joo Hee
Choi, Ae-Ran
Cho, Sung-Yeon
Park, Chulmin
Lee, Dong-Gun
Oh, Eun-Jee
Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus
title Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus
title_full Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus
title_fullStr Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus
title_full_unstemmed Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus
title_short Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus
title_sort evaluation of a newly developed rapid automated fluorescent lateral flow immunoassay to detect igg and igm antibodies to chikungunya virus
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779981/
https://www.ncbi.nlm.nih.gov/pubmed/32757502
http://dx.doi.org/10.3947/ic.2020.52.4.611
work_keys_str_mv AT leehyeyoung evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus
AT ryujihyeong evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus
AT yunsojeong evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus
AT jangjoohee evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus
AT choiaeran evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus
AT chosungyeon evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus
AT parkchulmin evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus
AT leedonggun evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus
AT oheunjee evaluationofanewlydevelopedrapidautomatedfluorescentlateralflowimmunoassaytodetectiggandigmantibodiestochikungunyavirus